MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Fatigue and depression are predictors of the tremor form of Parkinson’s disease

    E. Kolupaeva, I. Zhukova, M. Nikitina, N. Zhukova, A. Latypova, O. Izhboldina, I. Mironova, M. Zhestikova, M. Titova, J. Kislukhina (Tomsk, Russian Federation)

    Objective: The principal objective is to study the relationship between fatigue and depression with the peculiarities of the progress of PD. Background: Parkinson's disease (PD)…
  • 2018 International Congress

    Dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder

    P. Wu, H. Yu, Z. Huang, C. Zuo (Shanghai, China)

    Objective: This study is to investigate the correlations between the abnormalities in the distribution of striatal dopamine transporter (DAT) and the expression of Parkinson's disease…
  • 2018 International Congress

    No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

    F. Hopfner, S. Müller, D. Steppat, J. Miller, N. Schmidt, K.P. Wandinger, F. Leypoldt, D. Berg, A. Franke, W. Lieb, L. Tittmann, M. Balzer-Geldsetzer, S. Baudrexel, R. Dodel, R. Hilker-Roggendorf, E. Kalbe, J. Kassubek, T. Klockgether, I. Liepelt-Scarfone, B. Mollenhauer, P. Neuser, K. Reetz, O. Riedel, C. Schulte, J. Schulz, A. Spottke, A. Storch, C. Trenkwalder, G. Deuschl, G. Kuhlenbäumer (Kiel, Germany)

    Objective: We measured NMDA antibodies in a large, well phenotyped sample of Parkinson patients without and with cognitive impairment (n = 297) and controls (n…
  • 2018 International Congress

    No MPTP-induced behavioral deficits or Striatal field potential alterations in crossbreds of MPTP-susceptible and MPTP-resistant mice strains

    P. Alladi, D. Vidyadhara, S. Arun, B. Kutty (Bengaluru, India)

    Objective: To evaluate the electrophysiological and motor behavioural correlates of strain-dependent differential susceptibility of mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the role of admixing thereon. Background:…
  • 2018 International Congress

    Pupil evaluation as the test for the clinical manifestations of Parkinson’s disease

    T. Araga, M. Shiraishi, K. Shinohara, Y. Hasegawa (Kawasaki, Japan)

    Objective: We clarify the correlation between abnormality in 123I-metaiodobenzylguanidine (MIBG) scintigraphy and task-evoked pupillary response in Parkinson's disease (PD) patients. Background: MIBG scintigraphy is one…
  • 2018 International Congress

    Bone health and laboratorial correlations of Vitamin D in Parkinson’s disease

    L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)

    Objective: To evaluate the correlation between levels of 25 (OH)D (Vitamin D) and Bone Mineral Density (BMD) in a parkinsonian population. Background: Considering a limiting…
  • 2018 International Congress

    Tau and α-synuclein autoantibodies as potential biomarkers for Parkinson’s and Alzheimer’s diseases

    A. Shalash, M. Salama, M. Makar, T. Roushdy, M. El-Balkimy (Cairo, Egypt)

    Objective: To investigate the value of the naturally occurring serum AIAs of α-synuclein (α-syn) and tau, proteins as potential biomarker for diagnosis of PD in…
  • 2018 International Congress

    Partial depletion of peripheral M1 macrophages ameliorates the neuroinflammation and dopaminergic neuronal death in the brain of a MPTP-induced mouse model of PD

    A. Yan, Y. Zhang, J. Lin, L. Song, X. Wang, Z. Liu (Shanghai, China)

    Objective: Neuroinflammation in the PD brain involves the activation of microglia and the increasing levels of inflammatory cytokines. Several studies have shown that the peripheral…
  • 2018 International Congress

    Dietary habits, motor and cognitive impairment in Parkinson’s Disease

    A. Pilotto, MC. Rizzetti, m. Oppini, C. passeri, A. Alberici, R. Turrone, M. Cosseddu, D. Placidi, M. Turla, b. Borroni, R. Lucchini, A. Padovani (Brescia, Italy)

    Objective: To evaluate the relationship between dietary habits, motor and cognitive impairment in Parkinson's disease patients with both cross-sectional and longitudinal design Background: Diet and…
  • 2018 International Congress

    Examining Parkinson’s disease psychosis treatment outcomes in the real world: The insyte observational study

    J. Goldman, D. Fredericks, C. Heywood, A. Ryan, A. Shim (Chicago, IL, USA)

    Objective: The INSYTE Study–seeks to gain a better understanding of the management of PDP. INSYTE will describe the relative safety and effectiveness of various antipsychotic…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 177
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley